Toll-like receptor signaling and its role in cell-mediated immunity

T Duan, Y Du, C Xing, HY Wang, RF Wang - Frontiers in Immunology, 2022 - frontiersin.org
Innate immunity is the first defense system against invading pathogens. Toll-like receptors
(TLRs) are well-defined pattern recognition receptors responsible for pathogen recognition …

Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma

TN Gide, JS Wilmott, RA Scolyer, GV Long - Clinical Cancer Research, 2018 - AACR
Immune checkpoint inhibitors have revolutionized the treatment of patients with advanced-
stage metastatic melanoma, as well as patients with many other solid cancers, yielding long …

Roles of regulatory T cells in cancer immunity

Y Takeuchi, H Nishikawa - International immunology, 2016 - academic.oup.com
Abstract CD4+ regulatory T cells (T regs) expressing the transcription factor FoxP3 are
highly immune suppressive and play central roles in the maintenance of self-tolerance and …

Regulatory T cells in cancer immunotherapy

H Nishikawa, S Sakaguchi - Current opinion in immunology, 2014 - Elsevier
Highlights•The vital role of FOXP3+ CD25+ CD4+ regulatory T (Treg) cells in tumor immunity
is described.•FOXP3+ CD25+ CD4+ Treg cells are abundantly present in tumor tissues and …

NKTR-214, an engineered cytokine with biased IL2 receptor binding, increased tumor exposure, and marked efficacy in mouse tumor models

DH Charych, U Hoch, JL Langowski, SR Lee… - Clinical Cancer …, 2016 - AACR
Purpose: Aldesleukin, recombinant human IL2, is an effective immunotherapy for metastatic
melanoma and renal cancer, with durable responses in approximately 10% of patients; …

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma

J Fan, MF Wang, HL Chen, D Shang, JK Das, J Song - Molecular cancer, 2020 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is an incurable cancer resistant to traditional
treatments, although a limited number of early-stage patients can undergo radical resection …

Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions

A Filatenkov, J Baker, AMS Mueller, J Kenkel… - Clinical Cancer …, 2015 - AACR
Purpose: The goals of the study were to elucidate the immune mechanisms that contribute to
desirable complete remissions of murine colon tumors treated with single radiation dose of …

Regulatory T cells: barriers of immune infiltration into the tumor microenvironment

EN Scott, AM Gocher, CJ Workman… - Frontiers in …, 2021 - frontiersin.org
Regulatory T cells (Tregs) are key immunosuppressive cells that promote tumor growth by
hindering the effector immune response. Tregs utilize multiple suppressive mechanisms to …

[HTML][HTML] The immunobiology of cancer immunosurveillance and immunoediting

GP Dunn, LJ Old, RD Schreiber - Immunity, 2004 - cell.com
The last fifteen years have seen a reemergence of interest in cancer immunosurveillance
and a broadening of this concept into one termed cancer immunoediting. The latter …

Cancer stem cells and immunosuppressive microenvironment in glioma

Q Ma, W Long, C Xing, J Chu, M Luo… - Frontiers in …, 2018 - frontiersin.org
Glioma is one of the most common malignant tumors of the central nervous system and is
characterized by extensive infiltrative growth, neovascularization, and resistance to various …